209401-69-4 Usage
General Description
(4aS,7aS)-octahydropyrrolo[3,4-b][1,4]oxazine is a chemical compound with a complex ring structure, belonging to the oxazine family. It is classified as a heterocyclic compound, containing both nitrogen and oxygen atoms in its ring. (4aS,7aS)-octahydropyrrolo[3,4-b][1,4]oxazine has been studied for its potential applications in the pharmaceutical industry, particularly in the development of novel drugs. Its unique structure and properties make it an interesting target for drug discovery research. Additionally, it may have potential uses in other industries, such as in the development of new materials or as a reagent in chemical reactions. Overall, (4aS,7aS)-octahydropyrrolo[3,4-b][1,4]oxazine is a versatile and intriguing chemical compound with potential applications in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 209401-69-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,9,4,0 and 1 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 209401-69:
(8*2)+(7*0)+(6*9)+(5*4)+(4*0)+(3*1)+(2*6)+(1*9)=114
114 % 10 = 4
So 209401-69-4 is a valid CAS Registry Number.
209401-69-4Relevant articles and documents
Use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of Helicobacter pylori infections and associated gastroduodenal diseases
-
, (2008/06/13)
PCT No. PCT/EP97/06781 Sec. 371 Date Jun. 14, 1999 Sec. 102(e) Date Jun. 14, 1999 PCT Filed Dec. 4, 1997 PCT Pub. No. WO98/26779 PCT Pub. Date Jun. 25, 1998The invention relates to the use of quinolone- and naphthyridonecarboxylic acid derivatives which a
Enantiomerically pure 2-oxa-5,8-diazabicyclo[4.3.0]nonanes and process for their preparation
-
, (2008/06/13)
The invention relates to enantiomerically pure 2-oxa-5,8-diazabicyclo[4.3.0]nonanes and processes for their preparation. The starting, intermediate and end products are as follows: STR1
